Related Experiment Video
Updated: Sep 23, 2025
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
17.9K
Neuropsychiatric Systemic Lupus Erythematosus: A Remaining Challenge
Daniel Mrak1, Michael Bonelli1, Helga Radner1
1Division of Rheumatology, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria.
Current Pharmaceutical Design
|May 13, 2022
Summary
Neuropsychiatric lupus (NPSLE) presents complex challenges in diagnosis and treatment due to limited biomarkers and sparse clinical trials. Recognizing NPSLE manifestations is crucial for developing a wider range of therapeutic options.
Area of Science:
- Immunology
- Neurology
- Rheumatology
Background:
- Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease with diverse organ involvement.
- Neuropsychiatric lupus (NPSLE) involves central and peripheral nervous systems, significantly increasing disease burden.
- NPSLE diagnosis and management remain challenging due to a lack of specific biomarkers and limited clinical trial data.
Purpose of the Study:
- To highlight the diagnostic and therapeutic challenges in Neuropsychiatric Lupus (NPSLE).
- To underscore the need for improved diagnostic tools and treatment strategies for NPSLE.
- To emphasize the growing recognition of NPSLE and the potential for expanded therapeutic options.
Main Methods:
- Review of current literature on Neuropsychiatric Lupus (NPSLE) manifestations.
- Analysis of diagnostic difficulties, including lack of specific biomarkers and imaging.
- Evaluation of existing therapeutic approaches and evidence base.
Main Results:
- NPSLE encompasses 19 distinct syndromes affecting the central and peripheral nervous systems.
- Diagnosis is complicated by non-specific symptoms and the absence of validated biomarkers or outcome measures.
- Current treatments rely on supportive care and immunosuppression, with limited evidence from clinical trials.
Conclusions:
- Neuropsychiatric Lupus (NPSLE) poses significant clinical challenges requiring further research.
- Development of specific biomarkers and validated outcome measures is essential for effective NPSLE management.
- Increased recognition of NPSLE is expected to drive the development of novel therapeutic strategies.
Keywords:
Central nervous systemautoimmune diseaseconstitutional symptomsneuropsychiatric systemic lupus erythematosusperipheral nervous systemsystemic lupus erythematosusMore Related Videos
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
32
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
32
01:29Autoimmune Disorders
698
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
698
01:24Nephrotic Syndrome I : Introduction
41
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
41
01:24Nephrotic Syndrome III : Nursing Management
57
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
57
01:26Psychosis: Goals of Pharmacotherapy
223
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
223
01:28Drug Therapy
108
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
108